115 related articles for article (PubMed ID: 9609696)
1. Calcium is not required for 5-lipoxygenase activity at high phosphatidyl choline vesicle concentrations.
Skorey KI; Gresser MJ
Biochemistry; 1998 Jun; 37(22):8027-34. PubMed ID: 9609696
[TBL] [Abstract][Full Text] [Related]
2. Human 5-lipoxygenase associates with phosphatidylcholine liposomes and modulates LTA4 synthetase activity.
Noguchi M; Miyano M; Matsumoto T; Noma M
Biochim Biophys Acta; 1994 Dec; 1215(3):300-6. PubMed ID: 7811715
[TBL] [Abstract][Full Text] [Related]
3. Modulation of human 5-lipoxygenase activity by membrane lipids.
Pande AH; Moe D; Nemec KN; Qin S; Tan S; Tatulian SA
Biochemistry; 2004 Nov; 43(46):14653-66. PubMed ID: 15544336
[TBL] [Abstract][Full Text] [Related]
4. Interfacial catalysis and production of a high ratio of leukotriene A4 to 5-HPETE by 5-lipoxygenase in a coupled assay with phospholipase A2.
Riendeau D; Falgueyret JP; Meisner D; Sherman MM; Laliberté F; Street IP
J Lipid Mediat; 1993; 6(1-3):23-30. PubMed ID: 8395245
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological cross-reactivity between 5-lipoxygenase-activating protein, 5-lipoxygenase, and leukotriene C4 synthase.
Gupta N; Nicholson DW; Ford-Hutchinson AW
Can J Physiol Pharmacol; 1997; 75(10-11):1212-9. PubMed ID: 9431445
[TBL] [Abstract][Full Text] [Related]
6. 5-Hydroxyeicosatetraenoic acid is a key intermediate of the arachidonate-dependent protective signaling in monocytes/macrophages exposed to peroxynitrite.
Tommasini I; Guidarelli A; Palomba L; Cerioni L; Cantoni O
J Leukoc Biol; 2006 Oct; 80(4):929-38. PubMed ID: 16885503
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylcholine activation of bacterial phosphatidylinositol-specific phospholipase C toward PI vesicles.
Qian X; Zhou C; Roberts MF
Biochemistry; 1998 May; 37(18):6513-22. PubMed ID: 9572869
[TBL] [Abstract][Full Text] [Related]
8. Coactosin-like protein functions as a stabilizing chaperone for 5-lipoxygenase: role of tryptophan 102.
Esser J; Rakonjac M; Hofmann B; Fischer L; Provost P; Schneider G; Steinhilber D; Samuelsson B; Rådmark O
Biochem J; 2009 Dec; 425(1):265-74. PubMed ID: 19807693
[TBL] [Abstract][Full Text] [Related]
9. A novel role of 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid as an activator of the phosphatase activity catalyzed by plasma membrane Ca2+-ATPase.
Santos FT; Scofano HM; Barrabin H; Meyer-Fernandes JR; Mignaco JA
Biochemistry; 1999 Aug; 38(32):10552-8. PubMed ID: 10441152
[TBL] [Abstract][Full Text] [Related]
10. Isolation and some properties of dioxygenase and co-oxidase activities of adult human liver cytosolic lipoxygenase.
Roy SK; Kulkarni AP
J Biochem Toxicol; 1996; 11(4):161-74. PubMed ID: 9062846
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of immunoaffinity-purified porcine 5-lipoxygenase to inhibitors and activating lipid hydroperoxides.
Riendeau D; Falgueyret JP; Nathaniel DJ; Rokach J; Ueda N; Yamamoto S
Biochem Pharmacol; 1989 Jul; 38(14):2313-21. PubMed ID: 2502118
[TBL] [Abstract][Full Text] [Related]
12. 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase.
Abramovitz M; Wong E; Cox ME; Richardson CD; Li C; Vickers PJ
Eur J Biochem; 1993 Jul; 215(1):105-11. PubMed ID: 8344271
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the mechanism of non-turnover-dependent inactivation of purified human 5-lipoxygenase. Inactivation by H2O2 and inhibition by metal ions.
Percival MD; Denis D; Riendeau D; Gresser MJ
Eur J Biochem; 1992 Nov; 210(1):109-17. PubMed ID: 1446663
[TBL] [Abstract][Full Text] [Related]
14. Shape changes and vesicle fission of giant unilamellar vesicles of liquid-ordered phase membrane induced by lysophosphatidylcholine.
Tanaka T; Sano R; Yamashita Y; Yamazaki M
Langmuir; 2004 Oct; 20(22):9526-34. PubMed ID: 15491182
[TBL] [Abstract][Full Text] [Related]
15. Application of the ferrous oxidation-xylenol orange assay for the screening of 5-lipoxygenase inhibitors.
Cho YS; Kim HS; Kim CH; Cheon HG
Anal Biochem; 2006 Apr; 351(1):62-8. PubMed ID: 16442488
[TBL] [Abstract][Full Text] [Related]
16. Development of 5-lipoxygenase inhibitors--lessons from cellular enzyme regulation.
Werz O; Steinhilber D
Biochem Pharmacol; 2005 Aug; 70(3):327-33. PubMed ID: 15907806
[TBL] [Abstract][Full Text] [Related]
17. The aminosteroid phospholipase C antagonist U-73122 (1-[6-[[17-beta-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione) potently inhibits human 5-lipoxygenase in vivo and in vitro.
Feisst C; Albert D; Steinhilber D; Werz O
Mol Pharmacol; 2005 May; 67(5):1751-7. PubMed ID: 15684042
[TBL] [Abstract][Full Text] [Related]
18. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the activity and localization of 15-lipoxygenase-1 after introduction into human colorectal carcinoma Caco-2 cells.
Hsi LC; Kamitani H; Cornicelli JA; Eling TE
Prostaglandins Leukot Essent Fatty Acids; 2001; 64(4-5):217-25. PubMed ID: 11418015
[TBL] [Abstract][Full Text] [Related]
20. 5-Lipoxygenase activity in the human pancreas.
Mancini JA; Li C; Vickers PJ
J Lipid Mediat; 1993 Nov; 8(3):145-50. PubMed ID: 8268460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
